These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34544343)

  • 41. Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.
    Bai ZL; Li XS; Chen GY; Du Y; Wei ZX; Chen X; Zheng GE; Deng W; Cheng Y
    J Mol Neurosci; 2018 Nov; 66(3):428-436. PubMed ID: 30298298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia.
    Song X; Fan X; Li X; Zhang W; Gao J; Zhao J; Harrington A; Ziedonis D; Lv L
    Psychopharmacology (Berl); 2014 Jan; 231(2):319-25. PubMed ID: 24337064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
    Strassnig M; Miewald J; Keshavan M; Ganguli R
    Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antioxidant defense in overt and subclinical hypothyroidism.
    Reddy VS; Gouroju S; Suchitra MM; Suresh V; Sachan A; Srinivasa Rao PV; Bitla AR
    Horm Metab Res; 2013 Sep; 45(10):754-8. PubMed ID: 23828125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet.
    Zhan CD; Sindhu RK; Pang J; Ehdaie A; Vaziri ND
    J Hypertens; 2004 Oct; 22(10):2025-33. PubMed ID: 15361776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients.
    An H; Du X; Huang X; Qi L; Jia Q; Yin G; Xiao C; Huang XF; Ning Y; Cassidy RM; Wang L; Soares JC; Zhang XY
    Transl Psychiatry; 2018 Nov; 8(1):258. PubMed ID: 30498208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis.
    Surapaneni KM; Venkataramana G
    Indian J Med Sci; 2007 Jan; 61(1):9-14. PubMed ID: 17197733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies.
    Sindhu RK; Koo JR; Roberts CK; Vaziri ND
    Clin Exp Hypertens; 2004 Jan; 26(1):43-53. PubMed ID: 15000296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
    Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of oxidative stress in the resistance to imatinib in Tunisian patients with chronic myeloid leukemia: A retrospective study.
    Ammar M; Ben Mahmoud L; Medhaffar M; Ghozzi H; Sahnoun Z; Hakim A; Mseddi M; Elloumi M; Zeghal K
    J Clin Lab Anal; 2020 Feb; 34(2):e23050. PubMed ID: 31617242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial.
    Lee BJ; Lin JS; Lin YC; Lin PT
    Nutr J; 2014 Aug; 13():79. PubMed ID: 25092108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obtusifolin treatment improves hyperlipidemia and hyperglycemia: possible mechanism involving oxidative stress.
    Tang Y; Zhong Z
    Cell Biochem Biophys; 2014 Dec; 70(3):1751-7. PubMed ID: 25015065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene expression and alterations of antioxidant enzymes in spleen of rats exposed to fluoride.
    Shashi A; Thakur S
    J Trace Elem Med Biol; 2022 Jul; 72():126966. PubMed ID: 35286942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence of the benefit of an antioxidant therapy in children and teenagers with Down syndrome.
    Parisotto EB; Giaretta AG; Zamoner A; Moreira EA; Fröde TS; Pedrosa RC; Filho DW
    Res Dev Disabil; 2015; 45-46():14-20. PubMed ID: 26207872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study.
    Taylor JH; Jakubovski E; Gabriel D; Bloch MH
    J Child Adolesc Psychopharmacol; 2018 Sep; 28(7):474-484. PubMed ID: 29920116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.